Minnie Kuo insider trades: Pliant Therapeutics (PLRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Minnie reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | PLRX | ↓ Sell10b5-1 | 6,917 | $1.28 | $9K | Direct | Jan 22, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PLRX insiders
Open-market trades in the last 12 months
About Minnie Kuo's insider trades
Minnie Kuo is Chief Operating Officer at Pliant Therapeutics (PLRX). Since Jan 20, 2026, Minnie has reported no open-market purchases and 1 sale worth $9K on SEC Form 4. In the last 12 months: 1 sale ($9K).
1 sale (100% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include shares returned to the company (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PLRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.